502 Carnegie Center//Princeton, NJ 08540-6241//United States
101 Park Ave.//New York, NY 10178-0060//United States
Benjamin David Novak’s corporate practice focuses on equity financings, debt financings, corporate governance, securities matters, and mergers and acquisitions. He represents emerging growth companies in the US and abroad in various industries including technology and life sciences, as well as, angel investors, private equity firms, and venture capital funds.
Ben is an active member of the startup and venture capital community. He serves on the Board of Directors of the New Jersey Technology Council and on the Advisory Board of the William & Mary Business Law Review. Additionally, he routinely speaks at events and conferences on a variety of topics related to technology, entrepreneurship, and investing. Outside of his role at Morgan Lewis, Ben is personally an active angel investor, who invests primarily in East Coast based seed stage technology companies.
Prior to joining Morgan Lewis, Ben was an associate in the venture capital and technology practice of a prominent national law firm.
Represented Upskill, formerly APX Labs, an augmented reality technology company, in its Convertible Debt financing led by New Enterprise Associates
Represented 101 Edu, an edtech software company, in its Series Seed Preferred Stock financing
Represented gel-e, a clinical-stage life sciences company, in its Series Seed Preferred Stock financing
Represented Untethered Labs, a cybersecurity hardware and software company, in its Series A Preferred Stock financing
Represented Gridless Power, a cleantech hardware and software company, in its Series A-1 Preferred Stock financing
Represented Videolicious, a video software company, in its Series E Preferred Stock financing
Represented Inbox Health, a digitalhealth software company, in its Series Seed Preferred Stock financing
Represented Flowonix Medical, a medical device manufacturer, in its Series BB financing
Represented Theaprin Pharmaceuticals, a specialty pharmaceutical company, in its Common Stock financing
Represented SeventySix Capital in its investment in Vegas Stats & Information Network, a sports betting media network providing news, analysis, and proprietary data
Mergers & Acquisitions
Represented Corente, a software technology company, in its sale to Oracle
Represented General Econopak, a manufacturer of sterility maintenance, barrier protection, and sterile cleanroom products, in its $175 million sale to Steris Corporation
Represented SK Capital Partners in its acquisition of Tri-Tex, a global chemical company
Represented A&E Medical, a medical device company, in its sale to Vance Street Capital
Represented Richard Forman, the sole stockholder of Forman Mills, a retail chain and department store, in the sale of the company to Goode Partners
Represented SK Capital Partners in the sale of its portfolio company, Calabrian, a producer of liquid sulfur dioxide, to INEOS Enterprises
Awards and Affiliations
Board of Directors, New Jersey Technology Council
Advisory Board, William & Mary Business Law Review
New Leader of the Bar, New Jersey Law Journal (2019)
Scholarship and Leadership Award, American Law Institute and American Bar Association
Staff Editor, William & Mary Bill of Rights Journal
Editor-in-Chief and Founder, William & Mary Business Law Review
District of Columbia
College of William & Mary, Marshall-Wythe School of Law, 2010, J.D.
The College of New Jersey, 2007, B.S., Business Management, summa cum laude